Report overview
The global Biobetter market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
G-CSF Biobetters Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Biobetter include F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen and CSL Behring GmbH, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
This report aims to provide a comprehensive presentation of the global market for Biobetter, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobetter. This report contains market size and forecasts of Biobetter in global, including the following market information:
Global Biobetter Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Biobetter Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Biobetter companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biobetter manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biobetter Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biobetter Market Segment Percentages, by Type, 2023 (%)
G-CSF Biobetters
Insulin Biobetters
Erythropoietin Biobetters
Monoclonal Antibodies Biobetters
Others
Global Biobetter Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biobetter Market Segment Percentages, by Application, 2023 (%)
Cancer
Diabetes
Genetic Disease
Neurological Disorders
Others
Global Biobetter Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Biobetter Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biobetter revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Biobetter revenues share in global market, 2023 (%)
Key companies Biobetter sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Biobetter sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
F.Hoffmann-La Roche AG
Merck and Co.
Sanofi
SERVIER
Porton Biopharma
Eli Lily and Company
Novo Nordisk
Biogen
CSL Behring GmbH
Teva
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biobetter, market overview.
Chapter 2: Global Biobetter market size in revenue and volume.
Chapter 3: Detailed analysis of Biobetter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biobetter in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biobetter capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.